Recent Mergers and Acquisitions

Pfizer acquisition of Array BioPharma

Pfizer (NYSE: PFE), multinational pharmaceutical company, acquired Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on small molecule medicines, for $11.4 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.

Topics

Pfizer acquisition of Array BioPharma

Topics

Pfizer (NYSE: PFE), multinational pharmaceutical company, acquired Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on small molecule medicines, for $11.4 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.